Karin Nilsson (Former)
1 – 37 of 37
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Plasma neurofilament light protein correlates with diffusion tensor imaging metrics in frontotemporal dementia
(
- Contribution to journal › Article
-
Mark
Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis
(
- Contribution to journal › Article
-
Mark
Disappearance of familially aggregated paralysis agitans in subsequent generations: a 135-year follow up study
(
- Contribution to journal › Published meeting abstract
- 2019
-
Mark
Swedish Version of the Hayling Test : Clinical Utility in Frontotemporal Dementia Syndromes
(
- Contribution to journal › Article
-
Mark
Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia
(
- Contribution to journal › Article
-
Mark
CSF placental growth factor – a novel candidate biomarker of frontotemporal dementia
(
- Contribution to journal › Article
- 2018
-
Mark
Slowly progressive dementia caused by MAPT R406W mutations : Longitudinal report on a new kindred and systematic review
(
- Contribution to journal › Article
- 2014
-
Mark
Age-related incidence and family history in frontotemporal dementia: data from the Swedish dementia registry.
(
- Contribution to journal › Article
-
Mark
Frontotemporal dementia and its subtypes: a genome-wide association study.
(
- Contribution to journal › Article
-
Mark
Autosomal dominant cerebellar ataxia with slow ocular saccades, neuropathy and orthostatism: A novel entity?
(
- Contribution to journal › Article
-
Mark
A Swedish version of the Hayling Test – clinical validity in patients with a FTD complex disorder
2014) 9th International Conference on Frontotemporal Dementias 2014 In American Journal of Neurodegenerative Disease 3(Supplementary Issues 1). p.77-77(
- Contribution to journal › Published meeting abstract
- 2013
-
Mark
Frontotemporal dementia with a C9ORF72 expansion in a Swedish family: clinical and neuropathological characteristics.
(
- Contribution to journal › Article
-
Mark
Elevated plasma homocysteine level in vascular dementia reflects the vascular disease process.
(
- Contribution to journal › Article
- 2012
-
Mark
Plasma homocysteine, brain imaging and cognition in older patients with mental illness.
(
- Contribution to journal › Article
-
Mark
Elevated Plasma Homocysteine Level Is Not Primarily Related to Alzheimer's Disease.
(
- Contribution to journal › Article
-
Mark
The use of N-terminal pro-brain natriuretic Peptide to evaluate vascular disease in elderly patients with mental illness.
(
- Contribution to journal › Article
-
Mark
Diagnosis of frontotemporal dementia in Sweden. Data from the Swedish Dementia Registry.
2012) International Conference on Frontotemporal Dementias, 2012(
- Contribution to conference › Abstract
- 2011
-
Mark
C-reactive protein level is decreased in patients with Alzheimer's disease and related to cognitive function and survival time.
(
- Contribution to journal › Article
-
Mark
Survival in a large elderly population of patients with dementia and other forms of psychogeriatric diseases.
(
- Contribution to journal › Article
- 2010
-
Mark
Hereditary Parkinson's Disease of Unknown Genetic Cause in Two Families from Southern Sweden
2010) 24th Annual Symposium on Etiology, Pathogenesis and Treatment of Parkinsons Disease and Other Movement Disorders In Movement Disorders 25(6).(
- Contribution to journal › Published meeting abstract
-
Mark
Plasma Homocysteine and Cognition in Elderly Patients with Dementia or Other Psychogeriatric Diseases.
(
- Contribution to journal › Article
-
Mark
The clinical use of N-terminal-pro brain natriuretic peptide in elderly patients with mental illness.
(
- Contribution to journal › Article
-
Mark
Plasma homocysteine-a marker of vascular disease in elderly patients with mental illness.
(
- Contribution to journal › Article
-
Mark
Plasma homocysteine, apolipoprotein E status and vascular disease in elderly patients with mental illness.
(
- Contribution to journal › Article
- 2009
-
Mark
Reduced CSF CART in dementia with Lewy bodies.
(
- Contribution to journal › Article
-
Mark
A Swedish family with de novo alpha-synuclein A53T mutation: Evidence for early cortical dysfunction.
(
- Contribution to journal › Article
-
Mark
Association between plasma homocysteine levels and mortality in elderly patients with mental illness.
(
- Contribution to journal › Article
-
Mark
Plasma Homocysteine Levels and Different Forms of Vascular Disease in Patients with Dementia and Other Psychogeriatric Diseases.
(
- Contribution to journal › Article
- 2008
-
Mark
Plasma homocysteine and vascular disease in elderly patients with mental illness
(
- Contribution to journal › Scientific review
-
Mark
Homocysteine, cystatin C and N-terminal-pro brain natriuretic Peptide. Vascular risk markers in elderly patients with mental illness.
(
- Contribution to journal › Article
- 2004
-
Mark
The tau R406W mutation causes progressive presenile dementia with bitemporal atrophy
2004) Frontotemporal Dementias. 4th International Conference In Dementia and Geriatric Cognitive Disorders 17(4). p.298-301(
- Contribution to journal › Article
- 2002
-
Mark
Role of impaired renal function as a cause of elevated plasma homocysteine concentration in psychogeriatric patients.
(
- Contribution to journal › Article
- 2000
-
Mark
Treatment of cobalamin deficiency in dementia, evaluated clinically and with cerebral blood flow measurements
(
- Contribution to journal › Article
- 1996
-
Mark
Prevalence of thyroid hormone abnormalities in elderly patients with symptoms of organic brain disease.
(
- Contribution to journal › Article
-
Mark
Orthostatic hypotension in organic dementia: relationship between blood pressure, cortical blood flow and symptoms
1996) In Clinical autonomic research : official journal of the Clinical Autonomic Research Society 6(1). p.29-36(
- Contribution to journal › Article
- 1995
-
Mark
Long-term effects of tacrine on regional cerebral blood flow changes in Alzheimer's disease
(
- Contribution to journal › Article
- 1993
-
Mark
Oral tetrahydroaminoacridine treatment of Alzheimer's disease evaluated clinically and by regional cerebral blood flow and EEG
(
- Contribution to journal › Article